Purpose: Evaluation the optical coherence tomography angiogram changes in non-active sever thyroid related ophthalmopathy patients after cosmetic bone decompression
Methods: included 18 patients (25 eyes) with severe not active not compressive (NANC) TED who were candidates for decompression surgery for cosmetic reasons and A 3 × 3 mm macular scan was used to measure vessel density and RNFL thickness. Whole macular vessel density, in its superficial, deep and choriocapillaris layers were evaluated. Whole macular vessel density, in its superficial, deep and choriocapillaris layers were evaluated. The following data was extracted for each of layers: superior and inferior hemispheres, fovea, parafoveal vessel density, its superior and inferior hemispheres, and temporal, superior, nasal, and inferior quadrant.
Results: The mean RPC increased postoperatively, which was statistically significant in small vessels of peripapillary area. (p-value=0.045).The mean RNFL thickness decreased after surgery and it was statistically significant in the peripapillary (p-value= 0.032) and -Inferior-Hemifield area (p-value= 0.036). The choriocapillaris changes were significant in Superior-Hemifield (p-value= 0.031) and Fovea (p-value= 0.03).
Conclusion: thyroid associated orbitopathy patients have a tendency to decrease vascular density and correlated with disease activity more than stage of orbitopathy. There was not a strong an even discrepant results in linkage of RNFL thickness and other optic nerve function tests and TED patients status and it is needed to do studies with more epidemiologic power and same methodology of study to be more comparable.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.